
The ICMR study has indicated a 4.5-fold and 3.2-fold reduction in neutralising antibody levels against the Delta variant in those who were given one and two doses of Covishield, respectively, compared to an earlier SARS-CoV-2 version that had the D614G mutation (detected early last year).
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2TAWphW
via
IFTTT
0 comments:
Post a Comment